Rhogam Ultra-Filtered Plus
FDA Approves Diclegis for Pregnant Women Experiencing Nausea and Vomiting »
"The U.S. Food and Drug Administration today approved Diclegis (doxylamine succinate and pyridoxine hydrochloride) to treat pregnant women experiencing nausea and vomiting.
Diclegis is a delayed-release tablet intended for women who have"...
Read the FDA Approves Diclegis for Pregnant Women Experiencing Nausea and Vomiting article »
Rhogam Ultra-Filtered Plus
OVERDOSE
Repeated administration or increased dosage in Rh-negative individuals should not cause more severe or more frequent adverse reactions than the normal dose. Patients who receive RhoGAM or MICRhoGAM for Rh-incompatible transfusion should be monitored by clinical and laboratory means due to the risk of a hemolytic reaction.
CONTRAINDICATIONS
The use of RhoGAM and MICRhoGAM is contraindicated in Rh-positive individuals.
Last reviewed on RxList: 5/9/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Rhogam Ultra-Filtered Plus Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Parenting and Pregnancy
Get tips for baby and you.
Updated & New
